PRCT Q3'26 Results Expected November 4 After Market Close
PROCEPT BioRobotics is expected to report Q3'26 results at 4:00 p.m. ET on November 4. EPS is estimated at $(0.39).
Related stories
Kolte-Patil Returns to Profit as Q2 Revenue More Than Doubles
Kolte-Patil Developers reported consolidated net profit of ₹5.3 crore for FY27’s second quarter, versus a net loss of ₹10.4 crore a year earlier. Revenue more than doubled year on
M impact | EQUITY | Nov 03, 2026, 04:36 PM UTC
Kimco Realty Acquires Two Shopping Centers in Louisville
M impact | EQUITY | Nov 03, 2026, 04:35 PM UTC
SOPHiA GENETICS Reports Q3 2026 Revenue Growth and Reaffirms Outlook
Revenue rose 25% year over year to $24.3 million. The company expects 2026 revenue at the upper end of its $94 million to $96 million guidance range.
M impact | EQUITY | Nov 03, 2026, 04:33 PM UTC
Opera Reports Q3 Revenue of $182.8 Million, Adjusted EBITDA of $43.2 Million
Opera said revenue rose 20% year over year to $182.8 million, at the top of its $181–183 million guidance range. Adjusted EBITDA was $43.2 million, above its $41–43 million guidanc
M impact | EQUITY | Nov 03, 2026, 04:33 PM UTC
ChemoMetec Raises 2026/27 Guidance, Reports Preliminary Q1 Results
ChemoMetec lifted revenue guidance to DKK 570–605 million from DKK 560–590 million and EBITDA guidance to DKK 335–360 million from DKK 330–345 million. Preliminary Q1 revenue rose
M impact | EQUITY | Nov 03, 2026, 04:33 PM UTC
Palantir Raises 2026 Revenue Guidance After Q3 Revenue Climbs 96%
Palantir reported Q3 revenue of $2.313B, up 96% year over year, and raised full-year 2026 revenue guidance to $8.530B—$8.534B. U.S. commercial revenue was $984M, up 148%.
M impact | EQUITY | Nov 03, 2026, 04:32 PM UTC